Iqvia Launches AI-Powered Clinical Trial Financial Suite for Integrated Management.

Iqvia Holdings Inc., a leading healthcare technology and analytics company, has launched an AI-powered clinical trial financial suite for integrated management. The suite aims to optimize clinical studies, develop new therapeutic classes, and assess pharmaceutical efficacy. The company offers various services, including contract research and development, technology and analytics solutions, and integrated services. Net sales are distributed across the Americas, Europe and Africa, and Asia/Pacific regions.

IQVIA Holdings Inc. (NYSE:IQV), a leading healthcare technology and analytics company, has announced the launch of its Clinical Trial Financial Suite (CTFS), an AI-enabled platform designed to streamline and optimize financial management in clinical trials IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management^[1]. The suite aims to enhance the efficiency of clinical studies, facilitate the development of new therapeutic classes, and improve the assessment of pharmaceutical efficacy.

CTFS is designed to eliminate inefficiencies caused by siloed systems and fragmented processes, offering a unified approach to budgeting, contracting, forecasting, and payment workflows. The suite's first module, CTFS Site Payments, introduces end-to-end automation for one of the most complex trial processes. By leveraging agentic AI, this module automates budget setup, invoice processing, and anomaly detection, freeing up financial teams to focus on more productive tasks IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management^[1].

IQVIA's technology and operations experts have supported site and participant payments across more than 200 geographies, ensuring the solution's scalability and security. The platform is projected to reduce processing time by up to 50% IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management^[1].

Bernd Haas, Senior Vice President of Digital Products & Solutions at IQVIA, commented, "With CTFS, we are building the financial backbone for modern clinical trials—unified, globally scalable, and powered by agentic AI. From protocol to payments, we are connecting and simplifying financial processes into a seamless, transparent experience for sponsors, CROs, and study sites alike" IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management^[1].

CTFS Site Payments is slated for general commercial availability in Q1 2026, following a Q4 2025 sandbox release where early adopters will pilot the solution and collaborate on future needs IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management^[1].

IQVIA's portfolio of solutions is powered by IQVIA Connected Intelligence™, delivering actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, and extensive domain expertise. The company is committed to using AI responsibly, ensuring privacy, regulatory compliance, and patient safety IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management^[1].

In addition to CTFS, IQVIA offers contract research and development, technology and analytics solutions, and integrated services. Net sales are distributed across the Americas, Europe and Africa, and Asia/Pacific regions. The company is dedicated to accelerating the development and commercialization of innovative medical treatments to improve patient outcomes and population health worldwide IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management^[1].

The launch of CTFS underscores IQVIA's commitment to leveraging technology to enhance the efficiency and effectiveness of clinical trials, a critical component of the healthcare industry's innovation pipeline.